Etodolac PCD Pharma Franchise Company
Cafoli Lifecare offers a strong Etodolac PCD pharma franchise built on 8 formulations across tablets and topical ointment, all made at WHO-GMP certified facilities. This gives franchise partners a well-tolerated pain-and-inflammation line for orthopaedics and general practice.
What is Etodolac?
Etodolac is a non-steroidal anti-inflammatory drug (NSAID) with relative selectivity for the COX-2 enzyme, which gives it useful anti-inflammatory and analgesic action with comparatively lower gastrointestinal irritation than non-selective NSAIDs. Read its profile on MedlinePlus.
Therapeutic Applications
Etodolac is prescribed for osteoarthritis, rheumatoid arthritis, acute musculoskeletal pain, post-operative and dental pain, and soft-tissue injuries; the ointment adds a topical option for localised joint and muscle pain. Prescribers include orthopaedic surgeons, rheumatologists, general physicians and dentists.
Why Etodolac is a High-Potential Molecule for Distributors
Pain and inflammation are among the highest-volume prescribing areas in India, and etodolac's COX-2-preferential profile lets prescribers offer relief with a gentler GI risk than diclofenac or ibuprofen. Chronic arthritis patients repeat their NSAID for months, and having both oral and topical forms lets a distributor serve acute and maintenance needs from one molecule.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- MedlinePlus: Etodolac
- PubChem: Etodolac
Our formulations of Etodolac find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: